Etofine 90mg Capsule contains Etoricoxib, a selective COX-2 inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal conditions. It is commonly prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. By selectively inhibiting the cyclooxygenase-2 enzyme, Etofine reduces the production of prostaglandins responsible for pain and inflammation, providing effective relief while minimizing gastrointestinal side effects often seen with non-selective NSAIDs. Etofine 90mg is typically administered once daily, with or without food, based on the severity of symptoms and the patient’s response. It is important to use this medication under medical supervision, especially in individuals with cardiovascular risk factors, kidney or liver impairment, or a history of gastrointestinal ulcers. Common side effects may include headache, dizziness, hypertension, and gastrointestinal discomfort. Patients are advised to report any unusual symptoms such as chest pain, shortness of breath, or severe abdominal pain promptly. Etofine should be used at the lowest effective dose for the shortest duration necessary to control symptoms. It is contraindicated in patients with known hypersensitivity to Etoricoxib or other NSAIDs, and during the third trimester of pregnancy. Always consult a healthcare professional before starting or discontinuing Etofine 90mg Capsule.